Anzeige
Mehr »
Sonntag, 20.07.2025 - Börsentäglich über 12.000 News
Foremost Clean Energy: Auf dem Weg zu großen Entdeckungen im Saudi-Arabien des Urans
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40H8H | ISIN: BE0974487192 | Ticker-Symbol: TG40
Frankfurt
18.07.25 | 08:01
0,014 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OXURION NV Chart 1 Jahr
5-Tage-Chart
OXURION NV 5-Tage-Chart

Aktuelle News zur OXURION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoOXURION: Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025190Leuven, BELGIUM - July 17, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces it has secured the financing for the acquisition of...
► Artikel lesen
DiOXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC206Leuven, BELGIUM - July 15, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
MoOXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC180Leuven, BELGIUM - July 14, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
10.07.OXURION: Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis388Leuven, BELGIUM - July 10, 2025 at 5:45 PM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the fulfilment of the second condition precedent in...
► Artikel lesen
04.07.OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas313Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen
03.07.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC271Leuven, BELGIUM - July 3, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
OXURION Aktie jetzt für 0€ handeln
25.06.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC257Leuven, BELGIUM - June 25, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
19.06.OXURION: Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region361Leuven, BELGIUM - June 19, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the signing of a letter of intent (LOI) to acquire 70%...
► Artikel lesen
18.06.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC308Leuven, BELGIUM - June 18, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
12.06.OXURION: Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC337Leuven, BELGIUM - June 12, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
12.06.OXURION: Oxurion moves forward with the planned acquisition of Axiodis404Leuven, BELGIUM - June 12, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, announces the lifting of the condition precedent relating to the...
► Artikel lesen
11.06.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC275Leuven, BELGIUM - June 11, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
04.06.OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas341Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen
04.06.OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC329Leuven, BELGIUM - June 4, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
28.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC331Leuven, BELGIUM - May 28, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
22.05.OXURION: Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025348Leuven, BELGIUM - May 22, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, held its annual shareholders' meeting on May 13, 2025....
► Artikel lesen
20.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC310Leuven, BELGIUM - May 20, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
16.05.OXURION: Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO569Louvain, BELGIUM - May 16, 2025 at 8:30 AM CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a...
► Artikel lesen
12.05.OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC298Leuven, BELGIUM - May 12, 2025 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen
09.05.OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas343Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen
Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1